Atea Pharmaceuticals Inc

-

Assets, Funds, Holdings

Home | Sign Up | Log In
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
Atea Pharmaceuticals Inc
CIK #0001593899
EDGAR Form CIK 2011 - 2026
10-K [0001593899]
10-Q [0001593899]
3 [0001593899]
4 [0001593899]
8-K [0001593899]
D [0001593899]
SC 13D [0001593899]
SC 13G [0001593899]
Form 13D/13G Filer Form 13D/13G Subject Filed
BML Investment Partners LP Atea Pharmaceuticals Inc [2026-02-09]
Radoff Bradley Louis Atea Pharmaceuticals Inc [2025-03-04]
BML Investment Partners LP Atea Pharmaceuticals Inc [2024-12-16]
BML Investment Partners LP Atea Pharmaceuticals Inc [2024-02-07]
BML Investment Partners LP Atea Pharmaceuticals Inc [2023-10-02]
Tang Capital Partners LP Atea Pharmaceuticals Inc [2023-05-22]
Vanguard Group Inc Atea Pharmaceuticals Inc [2022-02-09]
BlackRock Inc Atea Pharmaceuticals Inc [2022-02-04]
EcoR1 Capital LLC Atea Pharmaceuticals Inc [2021-12-10]
RA Capital Management LP Atea Pharmaceuticals Inc [2021-02-16]
View All
Form 3/4/5 Subject 2011 - 2026
Kirsch Arthur S
Atea Pharmaceuticals Inc
Adams Jerome M
Berman Howard
Berger Franklin M
Lucidi Bruno
Duncan Barbara Gayle
Polsky Bruce
Murphy Polly A
Corcoran Andrea
Sommadossi Jean-Pierre
Horga Maria Arantxa
Vavricka John
Hammond Janet MJ
Foster Wayne
Cormorant Private Healthcare Fund I LP
Cormorant Asset Management LP
Cormorant Global Healthcare Master Fund LP
Chen Bihua
Cormorant Private Healthcare Fund II LP
Rock Springs Capital Master Fund LP
Rock Springs Capital Management LP
Rock Springs Capital LLC
Hack Andrew A F
Chu Chung K
Cheng Isaac
JPM Partners LLC
Insider Transaction (Form 3/4/5) Date Action Shares Price Value ($)
Atea Pharmaceuticals Inc AVIR
Stock Option (Right to Buy) · derivative
2026-03-11 Option exercise 60,000 $0.00
Atea Pharmaceuticals Inc AVIR
Common Stock
2026-03-11 Option exercise 60,000 $1.24 74,400
Atea Pharmaceuticals Inc AVIR
Stock Option (Right to Buy) · derivative
2026-02-03 Option exercise 300,000 $0.00
Atea Pharmaceuticals Inc AVIR
Common Stock
2026-02-03 Option exercise 300,000 $1.24 372,000
Atea Pharmaceuticals Inc AVIR
Common Stock
2026-01-31 Tax withheld 11,570 $4.24 49,057
Atea Pharmaceuticals Inc AVIR
Common Stock
2026-01-31 Option exercise 51,283
Atea Pharmaceuticals Inc AVIR
Common Stock
2026-01-31 Option exercise 54,866
Atea Pharmaceuticals Inc AVIR
Common Stock
2026-01-31 Tax withheld 16,104 $4.24 68,281
Atea Pharmaceuticals Inc AVIR
Common Stock
2026-01-31 Tax withheld 106,093 $4.24 449,834
Atea Pharmaceuticals Inc AVIR
Common Stock
2026-01-31 Tax withheld 16,073 $4.24 68,150
Atea Pharmaceuticals Inc AVIR
Common Stock
2026-01-31 Option exercise 272,983
Atea Pharmaceuticals Inc AVIR
Common Stock
2026-01-31 Tax withheld 12,132 $4.24 51,440
Atea Pharmaceuticals Inc AVIR
Common Stock
2026-01-31 Option exercise 41,333
Atea Pharmaceuticals Inc AVIR
Restricted Stock Units · derivative
2026-01-31 Option exercise 41,533 $0.00
Atea Pharmaceuticals Inc AVIR
Restricted Stock Units · derivative
2026-01-31 Option exercise 9,750 $0.00
Atea Pharmaceuticals Inc AVIR
Stock Option (Right to Buy) · derivative
2026-01-31 Grant 173,500 $0.00
Atea Pharmaceuticals Inc AVIR
Restricted Stock Units · derivative
2026-01-31 Option exercise 8,750 $0.00
Atea Pharmaceuticals Inc AVIR
Stock Option (Right to Buy) · derivative
2026-01-31 Grant 119,520 $0.00
Atea Pharmaceuticals Inc AVIR
Restricted Stock Units · derivative
2026-01-31 Option exercise 33,333 $0.00
Atea Pharmaceuticals Inc AVIR
Restricted Stock Units · derivative
2026-01-31 Option exercise 11,250 $0.00
showing 20 of 200 most recent transactions
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com